Home > Endocrinology > EASD 2020 > EASD 2020 Highlights Podcast

EASD 2020 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
EASD 2020
  Dr Rachel Giles guides us through 6 abstracts from the 56th EASD Annual Meeting: Ertugliflozin offers some kidney protection - Cherney et al. Empagliflozin significantly reduces CV and renal risk - Packer et al. Once daily oral treatment with glucokinase activator TTP399 reduced HbA1c in patients with type 1 diabetes - Valcarce et al. Diabetes still goes unnoticed, resulting in delayed diagnosis - Young et al. Once-weekly insulin is a promising treatment option - Rosenstock et al. Intermittent fasting: consuming fewer calories but in a different way - Varady et al.

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on